Multimodality approach to treat calciphylaxis in end-stage kidney disease patients-Reference-Cited by-同舟云学术

Multimodality approach to treat calciphylaxis in end-stage kidney disease patients

Published:2023-09-19 Issue:2 Volume:45 Page:
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Lajoie Chloé¹²,Ghanemi Abdelaziz³,Bourbeau Kateri¹,Sidibé Aboubacar³,Wang Yue-Pei³,Desmeules Simon³,Mac-Way Fabrice³

Affiliation:

1. CHU de Québec, L’Hôtel-Dieu de Québec Hospital, Faculty and Department of Pharmacy, Université Laval, Québec, Canada

2. Department of Pharmacy, CSSS de la Minganie, Québec, Canada

3. CHU de Québec Research Center, L’Hôtel-Dieu de Québec Hospital, Division of Nephrology, Faculty and Department of Medicine, Université Laval, Québec, Canada

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2023.2256413

Reference82 articles.

1. Calciphylaxis and its co‐occurrence with connective tissue diseases

2. Calciphylaxis and Kidney Disease: A Review

3. Calciphylaxis: Risk Factors, Diagnosis, and Treatment

4. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications

5. Calciphylaxis in CKD and beyond

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualizing the lifesaving journey for calciphylaxis: addressing rapidly progressive attacks with multidimensional and AI research for regenerative medicine;Renal Failure;2024-09-05

2. Multiple drugs;Reactions Weekly;2024-03-16

3. A Peculiar Presentation of a Debilitating Condition: Calciphylaxis;Cureus;2024-02-02